Newstral
Article
wsj.com on 2015-04-02 11:24
Pfizer to Cease Vaccine Sales Business in China
Related news
- FPfizer halts China vaccine salesft.com
- China approves Pfizer vaccine developed locallybizjournals.com
- Pfizer stops China vaccine sales as import license expiresThe Findlay Courier
- [Ticker] Pfizer expects €22bn in vaccine sales this yeareuobserver.com
- Scholz’s China visit secures BioNTech/Pfizer vaccine access for expatsPolitico.eu
- Coronavirus: Taiwan says talks to buy Pfizer-BioNTech child vaccine held up over Chinese sales rightsSouth China Morning Post
- Cease Taiwan arm sales, China warns U.S.punchng.com
- Vaccine sales power Pfizer through first quarterSeattle Times
- Report: Pfizer May Challenge China in Asian Market by Manufacturing Vaccine in Indiabreitbart.com
- China, World Champion of Forced Abortion, Worries Pfizer Vaccine May Hurt Pregnant Womenbreitbart.com
- Pfizer expects $15bn sales of Covid-19 vaccineBBC
- Pfizer predicts: We'll rake in $$ 33.5 billion in vaccine salesisraelnationalnews.com
- Pfizer Q1 profit, revenue soar on COVID-19 vaccine salesNew York Post
- TPfizer posts narrower Q3 loss amid slumping Covid vaccine salesthestreet.com
- FPfizer raises 2021 sales forecast for Covid vaccine to $36bnft.com
- Pfizer hikes 2021 outlook after vaccine boosts sales, profitSeattle Times
- BPfizer Expects $26B in Covid-19 Vaccine Sales This Yearbarrons.com
- Pfizer expects $26 billion in 2021 sales from COVID vaccineNew York Post
- Pfizer tops Q1 forecasts; vaccine sales slide as expectedseattletimes.com